Новая классификация идиопатических интерстициальных пневмоний: совместный документ Американского торакального и Европейского респираторного обществ

Полный текст:


Аннотация

По материалам: Travis W.D., Costabel U., Hansell D.M. et al. An official American Thoracic Society / European Respiratory Society Statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013, 188 (6): 733–748.


Об авторе

статья Редакционная

Россия


Список литературы

1. American Thoracic Society, European Respiratory Society. American Thoracic Society / European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2002; 165: 277–304.

2. Travis W.D., Hunninghake G., King T.E. et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am. J. Respir. Crit. Care Med. 2008; 177: 1338–1347.

3. Aziz Z.A., Wells A.U., Hansell D.M. et al. HRCT diagnosis of diffuse parenchymal lung disease: inter-observer variation. Thorax 2004; 59: 506–511.

4. Flaherty K.R., King T.E. Jr, Raghu G. et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am. J. Respir. Crit. Care Med. 2004; 170: 904–910.

5. Nicholson A.G., Addis B.J., Bharucha H. et al. Interobserver variation between pathologists in diffuse parenchymal lung disease. Thorax 2004; 59: 500–505.

6. Thomeer M., Demedts M., Behr J. et al. Idiopathic Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis. Eur. Respir. J. 2008; 31: 585–591.

7. Flaherty K.R., Andrei A.&C., King T.E. et al. Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am. J. Respir. Crit. Care Med. 2007; 175: 1054–1060.

8. Raghu G., Collard H.R., Egan J.J.et al. An official ATS / ERS / JRS / ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011; 183: 788–824.

9. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin. Chest Med. 2004; 25: 531–547, vi.

10. Lynch D.A., Newell J.D., Logan P.M. et al. Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis? Am. J. Roentgenol. 1995; 165: 807–811.

11. Silva C.I., Churg A., Muller N.L. Hypersensitivity pneumonitis: spectrum of high-resolution CT and pathologic findings. Am. J. Roentgenol. 2007; 188: 334–344.

12. Silva C.I.S., Muller N.L., Lynch D.A. et al. Chronic hypersensitivity pneumonitis: differentiation from idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia by using thin-section CT. Radiology 2008; 246: 288–297.

13. Akashi T., Takemura T., Ando N. et al. Histopathologic analysis of sixteen autopsy cases of chronic hypersensitivity pneumonitis and comparison with idiopathic pulmonary fibrosis/usual interstitial pneumonia. Am. J. Clin. Pathol. 2009; 131: 405–415.

14. Churg A., Muller N.L., Flint J., Wright J.L. Chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2006; 30: 201–208.

15. Churg A., Sin D.D., Everett D. et al. Pathologic patterns and survival in chronic hypersensitivity pneumonitis. Am. J. Surg. Pathol. 2009; 33: 1765–1770.

16. Fenton M.E., Cockcroft D.W., Wright J.L., Churg A. Hypersensitivity pneumonitis as a cause of airway-centered interstitial fibrosis. Ann. Allergy Asthma Immunol. 2007; 99: 465–466.

17. Sahin H., Brown K.K., Curran&Everett D. et al. Chronic hypersensitivity pneumonitis: CT features comparison with pathologic evidence of fibrosis and survival. Radiology 2007; 244: 591–598.

18. Hanak V., Golbin J.M., Ryu J.H. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin. Proc. 2007; 82: 812–816.

19. Felicio C.H., Parra E.R., Capelozzi V.L. Idiopathic and collagen vascular disease nonspecific interstitial pneumonia: clinical significance of remodeling process. Lung 2007; 185: 39–46.

20. Park J.H., Kim D.S., Park I.N. et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am. J. Respir. Crit. Care Med. 2007; 175: 705–711.

21. Hwang J.&H., Misumi S., Sahin H. et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J. Comput. Assist. Tomogr. 2009; 33: 410–415.

22. Song J.W., Do K.&H., Kim M.&Y. et al. Pathologic and radiologic differences between idiopathic and collagen vascular disease–related usual interstitial pneumonia. Chest 2009; 136: 23–30.

23. Corte T.J., Copley S.J., Desai S.R. et al. Significance of connective tissue disease features in idiopathic interstitial pneumonia. Eur. Respir. J. 2012; 39: 661–668.

24. Suda T., Kono M., Nakamura Y. et al. Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respir. Med. 2010; 104: 1527–1534.

25. Kinder B.W., Collard H.R., Koth L. et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am. J. Respir. Crit. Care Med. 2007; 176: 691–697.

26. Garcia&Sancho C., Buendia&Roldan I., Fernandez&Plata M.R. et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir. Med. 2011; 105: 1902–1907.

27. Hodgson U., Laitinen T., Tukiainen P. Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland. Thorax 2002; 57: 338–342.

28. Marshall R.P., Puddicombe A., Cookson W.O., Laurent G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 2000; 55: 143–146.

29. Barlo N.P., van Moorsel C.H.M., Ruven H.J.T. et al. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2009; 26: 155–161.

30. Nogee L.M., Dunbar A.E. III, Wert S.E. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 2001; 344: 573–579.

31. Kirwan M., Dokal I. Dyskeratosis congenita, stem cells and telomeres. Biochim. Biophys. Acta 2009; 1792: 371–379.

32. van Moorsel C.H., van Oosterhout M.F., Barlo N.P. et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am. J. Respir. Crit. Care Med. 2010; 182: 1419–1425.

33. Alder J.K., Chen J.J.L., Lancaster L. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 2008; 105: 13051–13056.

34. Cronkhite J.T., Xing C., Raghu G. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 729–737.

35. Lawson W.E., Crossno P.F., Polosukhin V.V. et al. Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection. Am. J. Physiol. Lung Cell Mol. Physiol. 2008; 294: L1119–L1126.

36. Seibold M.A., Wise A.L., Speer M.C. et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1503–1512.

37. Zhang Y., Noth I., Garcia J.G., Kaminski N. A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N. Engl. J. Med. 2011; 364: 1576–1577.

38. Lawson W.E., Loyd J.E., Degryse A.L. Genetics in pulmonary fibrosis – familial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am. J. Med. Sci. 2011; 341: 439–443.

39. Monaghan H., Wells A.U., Colby T.V. et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004; 125: 522–526.

40. Ryu J.H., Colby T.V., Hartman T.E., Vassallo R. Smokingrelated interstitial lung diseases: a concise review. Eur. Respir. J. 2001; 17: 122–132.

41. Aubry M.C., Wright J.L., Myers J.L. The pathology of smoking-related lung diseases. Clin. Chest Med. 2000; 21: 11–35, vii.

42. Vassallo R., Jensen E.A., Colby T.V. et al. The overlap between respiratory bronchiolitis and desquamative interstitial pneumonia in pulmonary Langerhans cell histiocytosis: high-resolution CT, histologic, and functional correlations. Chest 2003; 124: 1199–1205.

43. Cottin V., Le Pavec J., Prevot G. et al. Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome. Eur. Respir. J. 2010; 35: 105–111.

44. Cottin V., Cordier J.F. The syndrome of combined pulmonary fibrosis and emphysema. Chest 2009; 136: 1–2.

45. Cottin V., Nunes H., Brillet P.Y. et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586–593.

46. Mejia M., Carrillo G., Rojas&Serrano J. et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10–15.

47. Akira M., Inoue Y., Kitaichi M. et al. Usual interstitial pneumonia and nonspecific interstitial pneumonia with and without concurrent emphysema: thin-section CT findings. Radiology 2009; 251: 271–279.

48. Flaherty K.R., Travis W.D., Colby T.V. et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2001; 164: 1722–1727.

49. Flaherty K.R., Thwaite E.L., Kazerooni E.A. et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003; 58: 143–148.

50. Sverzellati N., Wells A.U., Tomassetti S. et al. Biopsyproved idiopathic pulmonary fibrosis: spectrum of nondiagnostic thin-section CT diagnoses. Radiology 2010; 254: 957–964.

51. Sumikawa H., Johkoh T., Colby T.V. et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433–439.

52. Silva C.I., Muller N.L., Hansell D.M. et al. Nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis: changes in pattern and distribution of disease over time. Radiology 2008; 247: 251–259.

53. Lynch D.A., Godwin J.D., Safrin S. et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am. J. Respir. Crit. Care Med. 2005; 172: 488–493.

54. Kim E.Y., Lee K.S., Chung M.P. et al. Nonspecific interstitial pneumonia with fibrosis: serial highresolution CT findings with functional correlation. Am. J. Roentgenol. 1999; 173: 949–953.

55. Hartman T.E., Swensen S.J., Hansell D.M. et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000; 217: 701–705. [Published erratum appears in Radiology 218: 606.]

56. Park J.S., Lee K.S., Kim J.S. et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995; 195: 645–648.

57. Cottin V., Donsbeck A.V., Revel D. et al. Nonspecific interstitial pneumonia: individualization of a clinicopathologic entity in a series of 12 patients. Am. J. Respir. Crit. Care Med.1998; 158: 1286–1293.

58. Nagai S., Kitaichi M., Itoh H. et al. Idiopathic nonspecific interstitial pneumonia / fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur. Respir. J. 1998; 12: 1010–1019.

59. Johkoh T., Muller N.L., Colby T.V. et al. Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients. Radiology 2002; 225: 199–204.

60. Johkoh T., Muller N.L., Cartier Y. et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999; 211: 555–560.

61. Nishiyama O., Kondoh Y., Taniguchi H. et al. Serial high resolution CT findings in nonspecific interstitial pneumonia / fibrosis. J. Comput. Assist. Tomogr. 2000; 24: 41–46.

62. MacDonald S.L., Rubens M.B., Hansell D.M. et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001; 221: 600–605.

63. Akira M., Inoue Y., Arai T. et al. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax 2011; 66: 61–65.

64. Katzenstein A.L., Fiorelli R.F. Nonspecific interstitial pneumonia / fibrosis: histologic features and clinical significance. Am. J. Surg. Pathol. 1994; 18: 136–147.

65. Travis W.D., Matsui K., Moss J., Ferrans V.J. Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am. J. Surg. Pathol. 2000; 24: 19–33.

66. Tsubamoto M., Muller N.L., Johkoh T. et al. Pathologic subgroups of nonspecific interstitial pneumonia: differential diagnosis from other idiopathic interstitial pneumonias on high-resolution computed tomography. J. Comput. Assist. Tomogr. 2005; 29: 793–800.

67. Park I.N., Jegal Y., Kim D.S. et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur. Respir. J. 2009; 33: 68–76.

68. Hidalgo A., Franquet T., Gimenez A. et al. Smoking-related interstitial lung diseases: radiologic–pathologic correlation. Eur. Radiol. 2006; 16: 2463–2470.

69. Craig P.J., Wells A.U., Doffman S. et al. Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking. Histopathology 2004; 45: 275–282.

70. Fraig M., Shreesha U., Savici D., Katzenstein A.L. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am. J. Surg. Pathol. 2002; 26: 647–653.

71. Vassallo R., Ryu J.H. Tobacco smoke-related diffuse lung diseases. Semin. Respir. Crit. Care Med. 2008; 29: 643–650.

72. Portnoy J., Veraldi K.L., Schwarz M.I. et al. Respiratory bronchiolitisinterstitial lung disease: long-term outcome. Chest 2007; 131: 664–671.

73. Doan M.L., Guillerman R.P., Dishop M.K. et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax 2008; 63: 366–373.

74. Bullard J.E., Wert S.E., Whitsett J.A. et al. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 2005; 172: 1026–1031.

75. Kawabata Y., Hoshi E., Murai K. et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008; 53: 707–714.

76. Katzenstein A.L., Mukhopadhyay S., Zanardi C., Dexter E. Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum. Pathol. 2010; 41: 316–325.

77. Snider G.L., Kleinerman J., Thurlbeck W.M., Bengali Z.H. The definition of emphysema: report of a National Heart, Lung, and Blood Institute, Division of Lung Diseases workshop. Am. Rev. Respir. Dis.1985; 132: 182–185.

78. King T.E., Mortenson R. Cryptogenic organizing pneumonitis: the North American experience. Chest 1992; 102(1, Suppl): 8S–13S.

79. Lee J.W., Lee K.S., Lee H.Y. et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. Am. J. Roentgenol. 2010; 195: 916–922.

80. Sen T., Udwadia Z.F. Cryptogenic organizing pneumonia: clinical profile in a series of 34 admitted patients in a hospital in India. J. Assoc. Physicians India 2008; 56: 229–232.

81. Oymak F.S., Demirbas H.M., Mavili E. et al. Bronchiolitis obliterans organizing pneumonia: clinical and roentgenological features in 26 cases. Respiration 2005; 72: 254–262.

82. Lee J.S., Lynch D.A., Sharma S. et al. Organizing pneumonia: prognostic implication of high-resolution computed tomography features. J. Comput. Assist. Tomogr. 2003; 27: 260–265.

83. Lee K.S., Kullnig P., Hartman T.E., Muller N.L. Cryptogenic organizing pneumonia: CT findings in 43 patients. Am. J. Roentgenol. 1994; 162: 543–546.

84. Muller N.L., Staples C.A., Miller R.R. Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. Am. J. Roentgenol. 1990; 154: 983–987.

85. Ujita M., Renzoni E.A., Veeraraghavan S. et al. Organizing pneumonia: perilobular pattern at thin–section CT. Radiology 2004; 232: 757–761.

86. Kim S.J., Lee K.S., Ryu Y.H. et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am. J. Roentgenol. 2003; 180: 1251–1254.

87. Epler G.R., Colby T.V., McLoud T.C. et al. Bronchiolitis obliterans organizing pneumonia. N. Engl. J. Med. 1985; 312: 152–158.

88. Lohr R.H., Boland B.J., Douglas W.W. et al. Organizing pneumonia: features and prognosis of cryptogenic, secondary, and focal variants. Arch. Intern. Med. 1997; 157: 1323–1329.

89. Lazor R., Vandevenne A., Pelletier A. et al. Cryptogenic organizing pneumonia: characteristics of relapses in a series of 48 patients. Am. J. Respir. Crit. Care Med. 2000; 162: 571–577.

90. Fischer A., Swigris J.J., du Bois R.M. et al. Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia. Respir. Med. 2009; 103: 1719–1724.

91. Bouros D., Nicholson A.C., Polychronopoulos V., du Bois R.M. Acute interstitial pneumonia. Eur. Respir. J. 2000; 15: 412–418.

92. Vourlekis J.S., Brown K.K., Cool C.D. et al. Acute interstitial pneumonitis: case series and review of the literature. Medicine (Baltimore) 2000; 79: 369–378.

93. Ichikado K., Suga M., Muller N.L. et al. Acute interstitial pneumonia: comparison of high-resolution computed tomography findings between survivors and nonsurvivors. Am. J. Respir. Crit. Care Med. 2002; 165: 1551–1556.

94. Primack S.L., Hartman T.E., Ikezoe J. et al. Acute interstitial pneumonia: radiographic and CT findings in nine patients. Radiology 1993; 188: 817–820.

95. Johkoh T., Muller N.L., Taniguchi H. et al. Acute interstitial pneumonia: thin-section CT findings in 36 patients. Radiology 1999; 211: 859–863.

96. Desai S.R., Wells A.U., Rubens M.B. et al. Acute respiratory distress syndrome: CT abnormalities at long-term follow-up. Radiology 1999; 210: 29–35.

97. Ichikado K., Suga M., Muranaka H. et al. Prediction of prognosis for acute respiratory distress syndrome with thin-section CT: validation in 44 cases. Radiology 2006; 238: 321–329.

98. Araya J., Kawabata Y., Jinho P. et al. Clinically occult subpleural fibrosis and acute interstitial pneumonia a precursor to idiopathic pulmonary fibrosis? Respirology 2008; 13: 408–412.

99. Rice A.J., Wells A.U., Bouros D. et al. Terminal diffuse alveolar damage in relation to interstitial pneumonias: an autopsy study. Am. J. Clin. Pathol. 2003; 119: 709–714.

100. Song J.W., Hong S.B., Lim C.M. et al. Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome. Eur. Respir. J. 2011; 37: 356–363.

101. Agarwal R., Jindal S.K. Acute exacerbation of idiopathic pulmonary fibrosis: a systematic review. Eur. J. Intern. Med. 2008; 19: 227–235.

102. Silva C.I.S., Muller N.L., Fujimoto K. et al. Acute exacerbation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J. Thorac. Imag. 2007; 22: 221–229.

103. Churg A., Muller N.L., Silva C.I.S., Wright J.L. Acute exacerbation (acute lung injury of unknown cause) in UIP and other forms of fibrotic interstitial pneumonias. Am. J. Surg. Pathol. 2007; 31: 277–284.

104. Suda T., Kaida Y., Nakamura Y. Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respir. Med. 2009; 103: 846–853.

105. Park I.N., Kim D.S., Shim T.S. et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007; 132: 214–220.

106. Miyazaki Y., Tateishi T., Akashi T. et al. Clinical predictors and histologic appearance of acute exacerbations in chronic hypersensitivity pneumonitis. Chest 2008; 134: 1265–1270.

107. Collard H.R., Moore B.B., Flaherty K.R. et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2007; 176: 636–643.

108. Akira M., Kozuka T., Yamamoto S., Sakatani M. Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2008; 178: 372–378.

109. Akira M., Hamada H., Sakatani M. et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am. J. Roentgenol. 1997; 168: 79–83.

110. Fujimoto K., Taniguchi H., Johkoh T. et al. Acute exacerbation of idiopathic pulmonary fibrosis: high-resolution CT scores predict mortality. Eur. Radiol. 2012; 22: 83–92.

111. Cha S.I., Fessler M.B., Cool C.D. et al. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur. Respir. J. 2006; 28: 364–369.

112. Johkoh T., Muller N.L., Pickford H.A. et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212: 567–572.

113. Reddy T.L., Tominaga M., Hansell D.M. et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur. Respir. J. 2012; 40: 377–385.

114. Becker C.D., Gil J., Padilla M.L. Idiopathic pleuroparenchymal fibroelastosis: an unrecognized or misdiagnosed entity? Mod. Pathol. 2008; 21: 784–787.

115. Frankel S.K., Cool C.D., Lynch D.A., Brown K.K. Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004; 126: 2007–2013.

116. von der Thusen J.H., Hansell D.M., Tominaga M. et al. Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation. Mod. Pathol. 2011; 24: 1633–1639.

117. Amitani R., Niimi A., Kuze F. Idiopathic pulmonary upper lobe fibrosis (IPUF) [in Japanese]. Kokyu 1992; 11: 693–699.

118. Watanabe K., Nagata N., Kitasato Y. et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir. Invest. 2012; 50: 88–97.

119. Beasley M.B., Franks T.J., Galvin J.R. et al. Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch. Pathol. Lab. Med. 2002; 126: 1064–1070.

120. Balduin R., Giacometti C., Saccarola L. et al. Acute fibrinous and organizing pneumonia in a patient with collagen vascular disease "stigma". Sarcoidos. Vasc. Diffuse Lung Dis. 2007; 24: 78–80.

121. Hariri L.P., Mino&Kenudson M., Shea B. et al. Distinct histopathology of acute onset or abrupt exacerbation of hypersensitivity pneumonitis. Hum. Pathol. 2012; 43: 660–668.

122. Yokogawa N., Alcid D.V. Acute fibrinous and organizing pneumonia as a rare presentation of abacavir hypersensitivity reaction. AIDS 2007; 21: 2116–2117.

123. Churg A., Myers J., Suarez T. et al. Airway-centered interstitial fibrosis: a distinct form of aggressive diffuse lung disease. Am. J. Surg. Pathol. 2004; 28: 62–68.

124. Fukuoka J., Franks T.J., Colby T.V. et al. Peribronchiolar metaplasia: a common histologic lesion in diffuse lung disease and a rare cause of interstitial lung disease: clinicopathologic features of 15 cases. Am. J. Surg. Pathol. 2005; 29: 948–954.

125. Yousem S.A., Dacic S. Idiopathic bronchiolocentric interstitial pneumonia. Mod. Pathol. 2002; 15: 1148–1153.

126. Mark E.J., Ruangchira Urai R. Bronchiolitis interstitial pneumonitis: a pathologic study of 31 lung biopsies with features intermediate between bronchiolitis obliterans organizing pneumonia and usual interstitial pneumonitis, with clinical correlation. Ann. Diagn. Pathol. 2008; 12: 171–180.

127. Ryerson C.J., Urbania T.H., Richeldi L. et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur. Respir. J. 2013; 42: 750–757.

128. Kinder B.W., Brown K.K., McCormack F.X. et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 2009; 135: 1557–1563.

129. Satoh H., Kurishima K., Ishikawa H., Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J. Intern. Med. 2006; 260: 429–434.

130. Prasse A., Probst C., Bargagli E. et al. Serum CC-chemokine ligand 18 concentration predicts outcome in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2009; 179: 717–723.

131. Prasse A., Pechkovsky D.V., Toews G.B. et al. CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis. Arthr. and Rheum. 2007; 56: 1685–1693.

132. Ishii H., Mukae H., Kadota J. et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003; 58: 52–57.

133. Ohnishi H., Yokoyama A., Kondo K. et al. Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases. Am. J. Respir. Crit. Care Med. 2002; 165: 378–381.

134. Casoni G.L., Ulivi P., Mercatali L. et al. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int. J. Biol. Markers 2010; 25: 229–235.

135. Pignatti P., Brunetti G., Moretto D. et al. Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006; 173: 310–317.

136. Ishii H., Mukae H., Kadota J. et al. Increased levels of interleukin-18 in bronchoalveolar lavage fluid of patients with idiopathic nonspecific interstitial pneumonia. Respiration 2005; 72: 39–45.

137. Choi E.S., Pierce E.M., Jakubzick C. et al. Focal interstitial CC chemokine receptor 7 (CCR7) expression in idiopathic interstitial pneumonia. J. Clin. Pathol. 2006; 59: 28–39.

138. Choi E.S., Jakubzick C., Carpenter K.J. et al. Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2004; 170: 508–515.

139. Yang I.V., Burch L.H., Steele M.P. et al. Gene expression profiling of familial and sporadic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2007; 175: 45–54.

140. Lawson W.E., Grant S.W., Ambrosini V. et al. Genetic mutations in surfactant protein C are a rare cause of sporadic cases of IPF. Thorax 2004; 59: 977–980.

141. Kim K.K., Flaherty K.R., Long Q. et al. A plasminogen activator inhibitor-1 promoter polymorphism and idiopathic interstitial pneumonia. Mol. Med. 2003; 9: 52–56.

142. Markart P., Ruppert C., Wygrecka M. et al. Surfactant protein C mutations in sporadic forms of idiopathic interstitial pneumonias. Eur. Respir. J. 2007; 29: 134–137.

143. Zorzetto M., Ferrarotti I., Campo I. et al. NOD2/CARD15 gene polymorphisms in idiopathic pulmonary fibrosis. Sarcoidos. Vasc. Diffuse Lung Dis. 2005; 22: 180–185.

144. Hutyrova B., Pantelidis P., Drabek J. et al. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2002; 165: 148–151.

145. Renzoni E., Lympany P., Sestini P. et al. Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis. Arthr. and Rheum. 2000; 43: 1633–1640.

146. Zorzetto M., Ferrarotti I., Trisolini R. et al. Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2003; 168: 330–334.

147. Hodgson U., Tukiainen P., Laitinen T. The polymorphism C5507G of complement receptor 1 does not explain idiopathic pulmonary fibrosis among the Finns. Respir. Med. 2005; 99: 265–267.

148. Kubistova Z., Mrazek F., Lympany P.A. et al. The CR1 C5507G polymorphism is not involved in susceptibility to idiopathic pulmonary fibrosis in two European populations. Tissue Antigens 2008; 72: 483–486.

149. Mushiroda T., Wattanapokayakit S., Takahashi A. et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J. Med. Genet. 2008; 45: 654–656.

150. Selman M., Lin H.&M., Montaño M. et al. Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum. Genet. 2003; 113: 542-550.

151. Falfán&Valencia R., Camarena A., Juárez A. et al. Major histocompatibility complex and alveolar epithelial apoptosis in idiopathic pulmonary fibrosis. Hum. Genet. 2005; 118: 235–244.

152. Checa M., Ruiz V., Montaño M. et al. MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis. Hum. Genet. 2008; 124: 465–472.

153. Matsushima H., Takayanagi N., Sakamoto T. et al. Pathologic findings both before and after steroid therapy in a case of desquamative interstitial pneumonia [article in Japanese]. Nihon Kokyuki Gakkai Zasshi 2001; 39: 609–614.

154. Latsi P.I., du Bois R.M., Nicholson A.G. et al. Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am. J. Respir. Crit. Care Med.2003; 168: 531–537.

155. Takahashi H., Fujishima T., Koba H. et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am. J. Respir. Crit. Care Med. 2000; 162: 1109–1114.

156. Greene K.E., King T.E., Kuroki Y. et al. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur. Respir. J. 2002; 19: 439–446.

157. Yokoyama A., Kondo K., Nakajima M. et al. Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology 2006; 11: 164–168.

158. Takahashi H., Shiratori M., Kanai A. et al. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D. Respirology 2006; 11: S51–S54.

159. Daniil Z.D., Papageorgiou E., Koutsokera A. et al. Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis. Pulm. Pharmacol. Ther. 2008; 21: 26–31.

160. Rosas I.O., Richards T.J., Konishi K. et al. MMP1 and MMP7 as American Thoracic Society Documents 747 potential peripheral blood biomarkers in idiopathic pulmonary fibrosis. PLoS Med. 2008; 5: e93.

161. Gilani S.R., Vuga L.J., Lindell K.O. et al. CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis. PLoS One 2010; 5: e8959.

162. Richards T.J., Kaminski N., Baribaud F. et al. Peripheral blood proteins predict mortality in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2012; 185: 67–76.

163. McKeown S., Richter A.G., O'Kane C. et al. MMP expression and abnormal lung permeability are important determinants of outcome in IPF. Eur. Respir. J. 2009; 33: 77–84.

164. Shinoda H., Tasaka S., Fujishima S. et al. Elevated CC chemokine level in bronchoalveolar lavage fluid is predictive of a poor outcome of idiopathic pulmonary fibrosis. Respiration 2009; 78: 285–292.

165. Richter A.G., McKeown S., Rathinam S. et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax 2009; 64: 156–161.


Дополнительные файлы

Для цитирования: Редакционная с. Новая классификация идиопатических интерстициальных пневмоний: совместный документ Американского торакального и Европейского респираторного обществ.  Пульмонология. 2013;(5):9-24.

For citation: . Novel classification of idiopathic interstitial pneumonias: statement of American Thoracic Society / European Respiratory Society. Russian Pulmonology. 2013;(5):9-24. (In Russ.)

Просмотров: 660

Обратные ссылки

  • Обратные ссылки не определены.


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)